Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMIODARONE Cause End stage renal disease? 87 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 87 reports of End stage renal disease have been filed in association with AMIODARONE (Amiodarone Hydrochloride). This represents 0.4% of all adverse event reports for AMIODARONE.

87
Reports of End stage renal disease with AMIODARONE
0.4%
of all AMIODARONE reports
72
Deaths
80
Hospitalizations

How Dangerous Is End stage renal disease From AMIODARONE?

Of the 87 reports, 72 (82.8%) resulted in death, 80 (92.0%) required hospitalization, and 71 (81.6%) were considered life-threatening.

Is End stage renal disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMIODARONE. However, 87 reports have been filed with the FAERS database.

What Other Side Effects Does AMIODARONE Cause?

Drug ineffective (2,223) Dyspnoea (2,182) Off label use (1,608) Drug interaction (1,589) Asthenia (1,452) Interstitial lung disease (1,421) Hyperthyroidism (1,410) Fatigue (1,269) Bradycardia (1,261) Atrial fibrillation (1,211)

What Other Drugs Cause End stage renal disease?

OMEPRAZOLE (10,356) ESOMEPRAZOLE (10,231) LANSOPRAZOLE (9,734) PANTOPRAZOLE (8,523) DEXLANSOPRAZOLE (4,800) RABEPRAZOLE (1,295) EMTRICITABINE\TENOFOVIR DISOPROXIL (721) TENOFOVIR DISOPROXIL (558) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (462) TACROLIMUS (361)

Which AMIODARONE Alternatives Have Lower End stage renal disease Risk?

AMIODARONE vs AMISULPRIDE AMIODARONE vs AMITRIPTYLINE AMIODARONE vs AMITRIPTYLINE\PERPHENAZINE AMIODARONE vs AMIVANTAMAB AMIODARONE vs AMIVANTAMAB-VMJW

Related Pages

AMIODARONE Full Profile All End stage renal disease Reports All Drugs Causing End stage renal disease AMIODARONE Demographics